CMO Nada Hindiyeh featured on Talking Head Pain

The Haven Team

June 14, 2024

•

4

min read

In this special episode of Talking Head Pain, Joe speaks with Dr. Nada Hindiyeh, Director of Headache Medicine at Metrodora Institute and CMO at Haven Headache & Migraine Center, and Dr. Lauren Natbony, Founder and CEO of Integrative Headache Medicine of New York. Recorded live at the American Headache Society’s (AHS) Annual Scientific Meeting in San Diego, CA, they discuss the complex interrelations between migraine, autonomic disorders such as POTS, Ehlers-Danlos Syndrome, and Mast Cell Activation Syndrome (MCAS). They highlight the importance of a holistic approach to treatment and the innovative work being done to create special interest groups within the AHS to address these issues. Listen here

‍

Share this post

The Haven Team

Editor

,

Haven Headache & Migraine Center

Frequently Asked Questions

No items found.

(function(){function b(d){var w=document.createElement('div');w.className='haven-table-embed';var t=document.createElement('table');var h=document.createElement('thead');var hr=document.createElement('tr');d.heads.forEach(function(c){var th=document.createElement('th');th.textContent=c;hr.appendChild(th);});h.appendChild(hr);t.appendChild(h);var tb=document.createElement('tbody');d.rows.forEach(function(r){var tr=document.createElement('tr');r.forEach(function(c){var td=document.createElement('td');td.textContent=c;tr.appendChild(td);});tb.appendChild(tr);});t.appendChild(tb);w.appendChild(t);return w;}var d1={heads:['Reported Trigger','What Patients Believe','What Controlled Studies Show','Evidence Strength'],rows:[['Skipping meals','Common trigger','Consistently triggers migraines across populations','Moderate-Strong'],['Caffeine withdrawal','Common trigger','RCTs confirm reliable trigger when intake stops','Moderate'],['Alcohol / red wine','High suspicion','Mixed results - varies by individual','Moderate'],['Aged cheese','Often blamed','Inconsistent - tyramine hypothesis unproven','Weak'],['Chocolate','Frequently blamed','All 3 provocation studies failed to show effect','Weak'],['MSG','Often blamed','Limited evidence; only triggered in liquid at high doses','Weak'],['Processed meats / nitrates','Moderate suspicion','Biologically plausible but mixed results','Weak-Moderate']]};var d2={heads:['Outcome','Effect Size','What It Means Clinically'],rows:[['Pain intensity','SMD -1.77 (large)','Roughly 2-3 point reduction on a 10-point scale'],['Headache duration','SMD -0.77 (moderate)','Estimated 2-4 hours shorter per attack'],['Headache frequency','SMD -1.91 (large)','Estimated 1-4 fewer headache days per month'],['Quality of life (HIT-6)','SMD -2.44 (very large)','Major improvement in work, social, and daily activities']]};[['haven-table-1',d1],['haven-table-2',d2]].forEach(function(pair){var el=document.getElementById(pair[0]);if(el)el.parentNode.replaceChild(b(pair[1]),el);});})();